Recursion Pharmaceuticals (RXRX) Divestments (2025)
Recursion Pharmaceuticals' (RXRX) quarterly Divestments came in at -$4.4 million in Q1 2025.
Recursion Pharmaceuticals (RXRX) Divestments (2025) Analysis & Trends
Recursion Pharmaceuticals (RXRX) has 1 years of Divestments data on file, last reported at -$4.4 million in Q1 2025.
- Quarterly Divestments changed N/A year-over-year to -$4.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$4.4 million (changed N/A YoY) and the FY2025 annual result came in at -$4.4 million, changed N/A from the prior year.
- Divestments was little changed at -$4.4 million in Q1 2025.
- In the past five years, Divestments ranged from a high of -$4.4 million in Q1 2025 to a low of -$4.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Recursion Pharmaceuticals | 1.69 Bn | 1.14 Bn | -3.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -4.44 Mn |